Antibiotic resistance in staphylococci

Waldvogel, 1995, Staphylococcus aureus (including toxic shock syndrome), 1754

Lowry, 1998, Staphylococcus aureus infections, New Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806

Reacher, 2000, Determination of trends in bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998, Br. Med. J., 320, 213, 10.1136/bmj.320.7229.213

Solberg CO. A study of carriers of Staphylococcus aureus. Acta Med Scand 1965; 178 (Suppl).

Oppenheim, 1998, The changing pattern of infection in neutropenic patients, Antimicrob. Chemother., 41, 7, 10.1093/jac/41.suppl_4.7

Hamory, 1987, Staphylococcus epidermidis: a significant nosocomial pathogen, Am. J. Infect. Control., 15, 59, 10.1016/0196-6553(87)90003-4

Abraham, 1941, Further observations on penicillin, Lancet, ii, 177, 10.1016/S0140-6736(00)72122-2

Barber, 1948, Infection by penicillin-resistant staphylococci, Lancet, ii, 641, 10.1016/S0140-6736(48)92166-7

Chen, 1993, Multi-centre survey of the comparative in vitro activity of piperacillin/tazobactam against bacteria from hospitalised patients in the British Isles, J. Antimicrob. Chemother., 32, 247, 10.1093/jac/32.2.247

Henwood CJ, Livermore DM, Johnson AP et al. A survey of the susceptibility of gram-positive cocci in 25 UK hospitals to linezolid and other antimicrobials. 2000; J. Antimicrob. Chemother. in press.

Richmond, 1965, Wild-type variants of exopenicillinase from Staphylococcus aureus, Biochem. J., 94, 584, 10.1042/bj0940584

East, 1989, Cloning and sequence determination of six Staphylococcus aureus β-lactamases and their expression in Escherichia coli and Staphylococcus aureus, J. Gen. Microbiol., 135, 1001

Lacey, 1984, Antibiotic resistance in Staphylococcus aureus and streptococci, Br. Med. Bull., 40, 77, 10.1093/oxfordjournals.bmb.a071951

Rountree, 1955, Infections caused by a particular phage type of Staphylococcus aureus, Med. J. Aust., ii, 157, 10.5694/j.1326-5377.1955.tb35001.x

Williams, 1959, Epidemic staphylococci, Lancet., i, 190, 10.1016/S0140-6736(59)90383-6

Livermore, 1996, β-Lactams: mode of action and mechanisms of bacterial resistance, 502

Jevons, 1961, Celbenin-resistant staphylococci, Br. Med. J., i, 124, 10.1136/bmj.1.5219.124-a

Hartman, 1984, Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus, J. Bacteriol., 158, 513, 10.1128/JB.158.2.513-516.1984

Hiramatsu, 1999, Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus, Balliere's Clin. Infect. Dis., 5, 221

Maidhof, 1991, femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains, J. Bacteriol., 173, 3507, 10.1128/jb.173.11.3507-3513.1991

Hartman, 1986, Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus, Antimicrob. Agents Chemother., 29, 85, 10.1128/AAC.29.1.85

Cohen, 1970, Transduction of methicillin resistance in Staphylococcus aureus dependent on an unusual specificity of the recipient strain, J. Bacteriol., 104, 1158, 10.1128/JB.104.3.1158-1167.1970

Thakker-Varia, 1999, Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci, Antimicrob. Agents Chemother., 31, 735, 10.1128/AAC.31.5.735

Kreiswirth, 1993, Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus, Science, 259, 227, 10.1126/science.8093647

Hiramatsu, 1998, Vancomycin resistance in staphylococci, Drug Res. Updates, 1, 135, 10.1016/S1368-7646(98)80029-0

Ayliffe, 1997, The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus, Clin. Infect. Dis., 24, S74, 10.1093/clinids/24.Supplement_1.S74

Rosdahl, 1991, The decline of methicillin resistance among Danish Staphylococcus aureus strains, Infect. Control. Hosp. Epidemiol., 12, 83, 10.1086/646291

Rouch, 1987, The aacA-aphD gentamicin and kanamycin resistance determinant of Tn-4001 from Staphylococcus aureus: expression and nucleotide sequence analysis, J. Gen. Microbiol., 133, 3039

1995, Epidemic methicillin-resistant Staphylococcus aureus, CDR, 5, 35

Lacey, 1987, Multi-resistant Staphylococcus aureus — a suitable case for inactivity?, J. Hosp. Infect., 9, 103, 10.1016/0195-6701(87)90046-6

1998, Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospital, J. Hosp. Infect., 39, 2532

Cox, 1995, Major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage type (EMRSA 16), J. Hosp. Infect., 29, 87, 10.1016/0195-6701(95)90191-4

Andrews, 1943, Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997, J. Antimicrob. Chemother., 1999, 689

Speller, Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–95, Lancet, 1997, 323

Voss, 1995, The worldwide prevalence of methicillin-resistant Staphylococcus aureus, Int. J. Antimicrob. Agents, 5, 101, 10.1016/0924-8579(94)00036-T

1998

Hashimoto, 1947, A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993, Jpn. J. Antibiot., 1994, 618

Kavi, 1987, Murpirocin-resistant Staphylococcus aureus, Lancet, ii, 1472, 10.1016/S0140-6736(87)91179-2

Marples, 1995, Prevalence of mupirocin resistance in Staphylococcus aureus, J. Hosp. Infect., 29, 153, 10.1016/0195-6701(95)90197-3

Yokoyama, 1990, Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistance S. aureus, Jpn. J. Antibiot., 43, 131

Otsuka, 1994, Efficacy of combination therapy against MRSA in Ibaraki Prefecture, Jpn. J. Antibiot., 47, 781

Noble, 1992, Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12 201 to Staphylococcus aureus, FEMS. Microbiol. Lett., 93, 195, 10.1111/j.1574-6968.1992.tb05089.x

Mejia-Villatoro CR, Mejia G, Martinez M et al. High-level resistance of Staphylococcus aureus to vancomycin (VRSA) in Guatemala strains, In: Abstracts of 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington, DC: American Society for Microbiology 652 (Abstract 2084) 1999.

Hiramatsu, 1997, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility, J. Antimicrob. Chemother., 40, 135, 10.1093/jac/40.1.135

1997, Staphylococcus aureus with reduced susceptibility to vancomycin — United States, MMWR, 46, 765

Ploy, 1998, First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital, Lancet, 351, 1212, 10.1016/S0140-6736(05)79166-2

Hiramatsu, 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin, Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8

Woodford, 2000, Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and Wales, J. Antimicrob. Chemother., 45, 258, 10.1093/jac/45.2.258

Aucken H, Warner M, Ganner M, et al. Twenty months of screening for vancomycin-intermediate Staphylococcus aureus. 2000: J. Antimicrob. Chemother. in press.

Vedel, 1990, Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs, Eur. J. Clin. Microbiol. Infect. Dis., 9, 820, 10.1007/BF01967381

Vandenbroucke-Grauls, 1993, Control of methicillin-resistant Staphylococcus aureus in the Netherlands, 75

Riley, 1994, Murpirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia, Med. J. Aust., 161, 397, 10.5694/j.1326-5377.1994.tb127503.x

Ohshita, 1990, A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus, Biochem. Biophys. Res. Comm., 172, 1028, 10.1016/0006-291X(90)91549-8

Nadler, 1999, Quinupristin/dalfopristin: a novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens, Clin. Microbiol. Newslett., 21, 103, 10.1016/S0196-4399(00)80041-0

Livermore, 2000, New antibiotics for gram-positive infections

Johnson, 2000, Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom, J. Antimicrob. Chemother., 45, 225, 10.1093/jac/45.2.225

Cocito, 1997, Inhibition of protein synthesis by streptogramins and related antibiotics, J. Antimicrob. Chemother., 39, 7, 10.1093/jac/39.suppl_1.7

Johnson, 1999, Synercid® (quinupristin/dalfopristin) joins the antimicrobial arsenal, Lancet, 354, 2012, 10.1016/S0140-6736(99)00344-X